rhNRG-1 and rhErbB3-f were recognized as "Shanghai high-tech achievement transformation projects"

In December 26, 2005, Zensun’s two proprietary research projects - recombinant human Neuregulin-1(rhNRG-1) (project number: 20050522) and recombinant human ErbB3 fragment (rhErbB3-f) immunization (project number: 20050523), were officially recognized as "Shanghai high-tech achievement transformation project "and obtained " Shanghai high-tech achievement transformation project "certificate.

The release as fetched from its publisher. zensun.com ↗